CT Angiography Biomarker Ctte

Co-chairs: Andrew Buckler, MS; Luca Saba, MD; Uwe Joseph Schoepf, MD, FAHA, FSCBT-MR, FNASCI, FSCCT Secretary: Julie Lisiecki

• Roster

Meetings

Recent Call Summaries:

• December 17, 2018
• November 19, 2018
• November 5, 2018
• October 22, 2018
• October 8, 2018
• September 24, 2018
• August 27, 2018
• August 13, 2018
• July 30, 2018

CT Angiography Call Summaries Archive

Project Snapshot - CT Angiography

The group intends to pursue writing quantitative profiles for both Coronary computed tomography angiography (CCTA) and CT angiography (CTA).

Excerpt from the biomarker committee submission form:

The QIBA Atherosclerosis Biomarkers Committee (ABC) is organized to document quantitative profiles for both Computed Tomography Angiography (CTA) and Coronary CTA (CCTA). The membership is composed of participants from multiple centers of excellence within North America and Europe utilizing different CTA vendors, acquisitions and scanner types, and analysis software vendors. Representatives from different manufacturers are included in the committee, who are interested in working closely with the committee in optimizing imaging biomarkers for scientific trials and clinical routine use. The Biomarker Committee develops technical performance standards to serve as atherosclerosis compositional biomarkers, engaging stakeholders from different societies, in addition to the RSNA, for example ASNR, SCCT, ACR, etc.

Profile Development

• QIBA Atherosclerosis Biomarkers Profile Draft | January 14, 2019
• QIBA Atherosclerosis Biomarkers Profile Draft | December 17, 2018
• QIBA Atherosclerosis Biomarkers Profile Draft | November 19, 2018
• QIBA Atherosclerosis Biomarkers Profile Draft | November 5, 2018
• QIBA Atherosclerosis Biomarkers Profile Draft | August 27, 2018
• QIBA Atherosclerosis Biomarkers Profile Draft | August 15, 2018

Reference Materials

• QIBA Biomarkers Selection Criteria Atherosclerosis Biomarker Committee (ABC) {Mr. Buckler} March 27, 2018 (PDF)